After the Federal Circuit’s denial last month of Regeneron’s motion for an injunction pending appeal, seeking to prevent Amgen from ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

Dr Arshad Khanani shares insights, including data on anti-VEGF treatment and macular atrophy, fibrosis biomarkers, and PCV combination therapies.

Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise in its latest trial results, the clinical-stage biopharma announced Monday. In a study that tested the highest dosage of ...

In addition to Viking Therapeutics, Regeneron, Amgen, Pfizer, and Zealand Pharma are all developing weight-loss drugs.

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

BigHat Biosciences is adding Synaffix’s antibody-drug conjugate (ADC) tech to its wardrobe, pairing the science with its antibody design platform to tailor a next-gen ADC pipeline. | BigHat ...

Thousand Oaks-based Amgen shared strong third-quarter results on Oct. 30, beating expectations, but all eyes appear to be on the big biotech's future, which includes trial data from its potentially ...

Hsiao is on the board of directors for the Hidradenitis Suppurativa Foundation and has declared relationships with AbbVie, ...

Background Pulmonary microvasculature alterations are implicated in emphysema pathogenesis, but the association between ...

Discover why Amgen is a reliable wealth compounder with strong Q3 results, a promising pipeline, debt reduction, and ...